Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 23344282)

1.

Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia.

Chay DB, Cho H, Kim BW, Kang ES, Song E, Kim JH.

Obstet Gynecol. 2013 Feb;121(2 Pt 1):321-9. doi: http://10.1097/AOG.0b013e31827c59f7.

PMID:
23344282
2.

Human papillomavirus 16 and 18 L1 serology in Korean women with high-grade cervical intraepithelial neoplasia and cervical cancer.

Jeong NH, Woo MK, Lee NW, Hur SJ, Choi KS, Kim HJ.

Arch Pharm Res. 2009 Jul;32(7):1013-8. doi: 10.1007/s12272-009-1706-z. Epub 2009 Jul 31.

PMID:
19641882
3.

Serologic response to human papillomavirus 16 among Australian women with high-grade cervical intraepithelial neoplasia.

Tabrizi SN, Frazer IH, Garland SM.

Int J Gynecol Cancer. 2006 May-Jun;16(3):1032-5.

PMID:
16803481
4.

Herpes simplex virus and human papillomavirus in a population-based case-control study of cervical intraepithelial neoplasia grade II-III.

Olsen AO, Orstavik I, Dillner J, Vestergaard BF, Magnus P.

APMIS. 1998 Mar;106(3):417-24.

PMID:
9548432
5.

Serologic response to human papillomavirus type 16 virus-like particles in Korean women with cervical precancerous and cancerous lesions.

Jeong NH, Lee NW, Woo MK, Kim HJ.

Arch Pharm Res. 2009 Mar;32(3):383-9. doi: 10.1007/s12272-009-1311-1. Epub 2009 Apr 23.

PMID:
19387582
6.

Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma.

Guo M, Sneige N, Silva EG, Jan YJ, Cogdell DE, Lin E, Luthra R, Zhang W.

Mod Pathol. 2007 Feb;20(2):256-66. Epub 2006 Dec 22.

7.

Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia.

Einstein MH, Studentsov YY, Ho GY, Fazzari M, Marks M, Kadish AS, Goldberg GL, Runowicz CD, Burk RD.

Int J Cancer. 2007 Jan 1;120(1):55-9.

PMID:
17036320
8.

Prevalence of HPV-DNA and anti-HPV antibodies in women from Girardot, Colombia.

Leon S, Sánchez R, Patarroyo MA, Camargo M, Mejia A, Urquiza M, Patarroyo ME.

Sex Transm Dis. 2009 May;36(5):290-6. doi: 10.1097/OLQ.0b013e318195762c.

PMID:
19295467
9.

Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.

Marais DJ, Rose RC, Lane C, Kay P, Nevin J, Denny L, Soeters R, Dehaeck CM, Williamson AL.

J Med Virol. 2000 Apr;60(4):403-10.

PMID:
10686023
10.

Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study.

Kjellberg L, Wang Z, Wiklund F, Edlund K, Angström T, Lenner P, Sjöberg I, Hallmans G, Wallin KL, Sapp M, Schiller J, Wadell G, Mählck CG, Dillner J.

J Gen Virol. 1999 Feb;80 ( Pt 2):391-8.

PMID:
10073699
11.

[Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].

Zhao FH, Hu SY, Wang SM, Chen F, Zhang X, Zhang WH, Pan QJ, Qiao YL.

Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Jul;43(7):565-70. Chinese.

PMID:
19954065
12.

IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.

Matsumoto K, Yoshikawa H, Yasugi T, Nakagawa S, Kawana K, Takeoka A, Yaegashi N, Iwasaka T, Kanazawa K, Taketani Y, Kanda T.

J Med Virol. 2003 Mar;69(3):441-6.

PMID:
12526056
13.
15.

[Study on the genotyping of human papillomavirus using a new DNA liquid chip in women of high-risk group of Shandong province].

Liu M, Wang CX, Deng XM, Wang LS, Zhang J, Li W, Zheng GX, Wang JF.

Zhonghua Liu Xing Bing Xue Za Zhi. 2007 May;28(5):487-90. Chinese.

PMID:
17877181
16.

Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study.

Bierl C, Karem K, Poon AC, Swan D, Tortolero-Luna G, Follen M, Wideroff L, Unger ER, Reeves WC.

Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S262-8. Epub 2005 Oct 17.

PMID:
16229879
17.

A population-based case-control study of human papillomavirus-type-16 seropositivity and incident high-grade dysplasia of the uterine cervix.

Olsen AO, Dillner J, Gjøen K, Sauer T, Orstavik I, Magnus P.

Int J Cancer. 1996 Nov 15;68(4):415-9.

PMID:
8945608
18.

[Diagnosis of human papillomavirus infection in paraffin-embedded cervical tissues by gene clip technology].

Lü YL, Zhong M, Zhao P.

Zhonghua Bing Li Xue Za Zhi. 2006 Dec;35(12):719-21. Chinese.

PMID:
17374254
19.

Cervicovaginal, oral, and serum IgG and IgA responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasia.

Passmore JA, Marais DJ, Sampson C, Allan B, Parker N, Milner M, Denny L, Williamson AL.

J Med Virol. 2007 Sep;79(9):1375-80.

PMID:
17607771
20.

Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea.

Kim CJ, Lee YS, Kwack HS, Yoon WS, Park TC, Park JS.

Int J Gynecol Cancer. 2010 Aug;20(6):1067-73. doi: 10.1111/IGC.0b013e3181e4a720.

PMID:
20683419
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk